Adynxx Inc., a stealth-mode biotechnology start-up based in San Francisco, raised $4.8 million in Series A financing, according to a filing with the S.E.C. The company plans to raise as much as $15.8 million, the filing said. The company’s board members include Dennis Podlesak and Eckard Weber, both partners with Princeton, N.J.-based venture firm Domain Associates.
Accera Inc., a Broomfield, Colo.-based commercial-stage biotechnology firm focused on neurodegenerative diseases, raised $11 million in new equity funding, according to a filing with the S.E.C. The company closed a $35 million in Series C funding in 2008, which included funding from Inventages Venture Capital and Posco BioVentures. The company’s board includes Bloodstone Ventures’ Claude Nash and Gunnar Weikert, Chairman, CEO and Founder of Inventages Venture Capital.
Zumbox raised $9.7 million, according to a S.E.C. filing, for digital mailbox technology designed to deliver snail mail via the Web. Zumbox is led by Chief Executive John Payne, who previously served as CEO of online postage company Stamps.com. Art Bilger, a managing director of Shelter Capital Partners, is on the Zumbox board of directors.
OpenGamma raised $6 million in venture capital financing from firms including Accel Partners and FirstMark Capital, according to a filing with the S.E.C. Based in London, the company is developing an open source financial analytics and risk management platform.
Rebit Inc. raised $1.5 million of a planned $3 million Series C-1 round, according to a filing with the S.E.C. The Longmont, Colo.-based company, which provides PC backup products, announced a $5.7 million in Series B funding in 2008 from investors including Access Venture Partners, Grotech Ventures, and Highway 12 Ventures.